{"id":748949,"date":"2025-07-08T04:21:47","date_gmt":"2025-07-08T09:21:47","guid":{"rendered":"https:\/\/www.capgemini.com\/us-en\/?p=748949&#038;preview=true&#038;preview_id=748949"},"modified":"2025-07-08T04:26:03","modified_gmt":"2025-07-08T09:26:03","slug":"the-future-of-pharma-mes","status":"publish","type":"post","link":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","title":{"rendered":"The future of pharma MES"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-blogs header-hero-blogs\"><div class=\"container\"><div class=\"hero-blogs\"><div class=\"hero-blogs-content-wrapper\"><div class=\"row\"><div class=\"col-12\"><div class=\"header-title\"><h1>The future of pharma MES<\/h1><\/div><\/div><\/div><\/div><div class=\"hero-blogs-bottom\"><div class=\"header-author\"><div class=\"author-img\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2021\/05\/cg-logo.png?w=200&amp;quality=10\" alt=\"Capgemini\" loading=\"lazy\"\/><\/div><div class=\"author-name-date\"><h5 class=\"author-name\">Capgemini<\/h5><h5 class=\"blog-date\">Sep 23, 2024<\/h5><\/div><\/div><div class=\"brand-image\"> <\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/?p=1058787\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.capgemini.com\/?p=1058787\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><div class=\"article-text article-quote-text\">\n<p>In our previous blog, we discussed the current state of Manufacturing Execution Systems (MES) in the pharmaceutical industry, highlighting the challenges and limitations faced today. As a natural sequel, this blog explores the future advancements in MES, promising greater integration, flexibility, and efficiency, and their potential impact on pharma manufacturing.<\/p>\n\n\n\n<p><strong>Seamless Integration<\/strong><br>In the future, we think that MES will be seamlessly integrated with other systems, creating a unified digital ecosystem. Users will be able to interact with a single, cohesive system without realizing the underlying complexities. This seamless integration will eliminate the need for custom-built interfaces and will ensure a smooth data flow across all systems.<\/p>\n\n\n\n<p><strong>Enhanced User Experience<\/strong><br>The future MES will also offer an intuitive user experience. Users will be able to interact with the system effortlessly, akin to driving a car without thinking about its mechanics. This user-friendly interface will make it easier for personnel to access and utilize data, thereby improving overall efficiency.<\/p>\n\n\n\n<p><strong>Support for Different Pharma Manufacturing Types<\/strong><br>Future MES systems will have the capability to support continuous manufacturing, personalized medicine manufacturing, and existing batch manufacturing.<\/p>\n\n\n\n<p><strong>Shift in Licensing Models<\/strong><br>Many pharma manufacturing companies will experiment with and adopt a SaaS licensing model. This shift will also motivate medium and small-sized companies to implement MES solutions.<\/p>\n\n\n\n<p><strong>Advanced Technologies<\/strong><\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><strong>AI and Machine Learning<\/strong>: AI and ML will play a significant role in the future of MES. These technologies will enable predictive analytics and anomaly detection, enhancing decision-making processes. For instance, AI can help identify variability in product output and suggest potential root causes, making it easier to address issues proactively.<\/li>\n\n\n\n<li><strong>Generative AI<\/strong>: The integration of generative AI will allow users to interact with MES through natural language, making data retrieval and analysis more accessible. This will enable operators to ask questions and receive insights in a conversational manner, further simplifying the use of MES.<\/li>\n\n\n\n<li><strong>Cloud-Based Solutions<\/strong>: The shift towards cloud-based MES may offer greater flexibility and scalability. Cloud solutions can make it easier to deploy and manage MES across multiple sites, providing a unified platform for global operations. As these systems mature, clients will evaluate on-premises vs. cloud risks and consider changes to their strategies to take advantage of benefits outlined above. However, addressing technical constraints like latency and ensuring robust security measures will be crucial for widespread adoption.<\/li>\n<\/ol>\n\n\n\n<p><strong>Sustainability and Efficiency<\/strong><br>Last but not least, Future MES will contribute to sustainability goals by optimizing resource usage and reducing waste. Integrating sustainability metrics into MES will drive greener manufacturing practices. For example, MES can help monitor and reduce energy consumption by optimizing equipment usage and minimizing waste.<\/p>\n\n\n\n<p><strong>Conclusion<\/strong><br>The future of MES in the pharmaceutical industry is bright, with advancements in integration, user experience, and technology set to transform manufacturing processes. By embracing these innovations, pharma companies can achieve greater efficiency, flexibility, and sustainability in their operations.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-wrapper-people-slider section section--expert-slider wrapper-people-slider undefined\"><div class=\"container\"><div class=\"content-title\"><h2 data-maxlength=\"34\" class=\"people-heading-title\">Authors<\/h2><\/div><\/div><div class=\"slider slider-boxed\"><div class=\"container\"><div class=\"slider-window\"><div class=\"slider-list\">\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2022\/01\/Brian-Eden-Pic.jpg\" alt=\"Brian Eden\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/brianleden\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Brian Eden<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Vice President, Global Life Sciences Technical Operations Leader, Capgemini<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/brianleden\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">Leading process and digital solutions in Pharma and Medical Device Operations \n \n\u201cWe are at an exciting moment when our data systems and analytics are finally capable of helping us fulfill the promise of Industry 4.0 for Pharma and Med Tech. We must move digital transformation forward boldly, all the while keeping our efforts grounded in the fundamentals of data architecture and Lean Thinking that got us to where we are today. \u201c\n<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\n\n\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2023\/04\/Larent-samot2.jpg\" alt=\"Laurent Samot\u00a0\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/laurent-samot-b97983\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Laurent Samot\u00a0<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Intelligent Manufacturing Leader<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Opens in a new window\" href=\"https:\/\/www.linkedin.com\/in\/laurent-samot-b97983\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">As global head of the COE Smart Factory, Laurent is working with our digital manufacturing practices to implement the fourth industrial revolution: Industry 4.0.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div><\/div><\/div><div class=\"slider-nav\"><button class=\"slider-prev inactive\" aria-label=\"Slider-previous\" tabindex=\"-1\"><\/button><ul class=\"slider-paginator\"><\/ul><button class=\"slider-next\" aria-label=\"Slider-next\"><\/button><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>In our previous blog, we discussed the current state of Manufacturing Execution Systems (MES) in the pharmaceutical industry, highlighting the challenges and limitations faced today. <\/p>\n","protected":false},"author":699,"featured_media":748950,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"3a01fe22-3dd4-4046-9453-7e4a1876466e\",\"blogId\":\"1\",\"domain\":\"www.capgemini.com\",\"sitePath\":\"\/\",\"postLink\":\"https:\/\/www.capgemini.com\/insights\/expert-perspectives\/the-future-of-pharma-mes\/\",\"postId\":1058787,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false,\"isEnabled\":true}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"_yoast_wpseo_primary_brand":"506","_jetpack_memberships_contains_paid_content":false,"footnotes":"","featured_focal_points":""},"categories":[1],"tags":[],"brand":[506],"service":[243],"industry":[73],"partners":[],"blog-topic":[285,396],"content-group":[],"class_list":["post-748949","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","brand-capgemini","service-data-ai","industry-life-sciences","blog-topic-innovation","blog-topic-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The future of pharma MES - Capgemini USA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The future of pharma MES\" \/>\n<meta property=\"og:description\" content=\"In our previous blog, we discussed the current state of Manufacturing Execution Systems (MES) in the pharmaceutical industry, highlighting the challenges and limitations faced today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini USA\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-08T09:21:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-08T09:26:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/10\/New-Web-preview-global.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Capgemini\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"elishavalekar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/\",\"url\":\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/\",\"name\":\"The future of pharma MES - Capgemini USA\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/us-en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg\",\"datePublished\":\"2025-07-08T09:21:47+00:00\",\"dateModified\":\"2025-07-08T09:26:03+00:00\",\"author\":{\"@id\":\"https:\/\/www.capgemini.com\/us-en\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg\",\"width\":2880,\"height\":1880},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.capgemini.com\/us-en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The future of pharma MES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/us-en\/#website\",\"url\":\"https:\/\/www.capgemini.com\/us-en\/\",\"name\":\"Capgemini USA\",\"description\":\"Just another www.capgemini.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/us-en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.capgemini.com\/us-en\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b\",\"name\":\"elishavalekar\",\"url\":\"https:\/\/www.capgemini.com\/us-en\/author\/elishavalekar\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"The future of pharma MES - Capgemini USA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","og_locale":"en_US","og_type":"article","og_title":"The future of pharma MES","og_description":"In our previous blog, we discussed the current state of Manufacturing Execution Systems (MES) in the pharmaceutical industry, highlighting the challenges and limitations faced today.","og_url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","og_site_name":"Capgemini USA","article_published_time":"2025-07-08T09:21:47+00:00","article_modified_time":"2025-07-08T09:26:03+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/10\/New-Web-preview-global.jpg","type":"image\/jpeg"}],"author":"Capgemini","twitter_card":"summary_large_image","twitter_misc":{"Written by":"elishavalekar","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","name":"The future of pharma MES - Capgemini USA","isPartOf":{"@id":"https:\/\/www.capgemini.com\/us-en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg","datePublished":"2025-07-08T09:21:47+00:00","dateModified":"2025-07-08T09:26:03+00:00","author":{"@id":"https:\/\/www.capgemini.com\/us-en\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b"},"breadcrumb":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#primaryimage","url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg","contentUrl":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg","width":2880,"height":1880},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/us-en\/"},{"@type":"ListItem","position":2,"name":"The future of pharma MES"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/us-en\/#website","url":"https:\/\/www.capgemini.com\/us-en\/","name":"Capgemini USA","description":"Just another www.capgemini.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/us-en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.capgemini.com\/us-en\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b","name":"elishavalekar","url":"https:\/\/www.capgemini.com\/us-en\/author\/elishavalekar\/"}]}},"blog_topic_info":[{"id":285,"name":"Innovation"},{"id":396,"name":"Technology"}],"taxonomy_info":{"category":[{"id":1,"name":"Uncategorized","slug":"uncategorized"}],"brand":[{"id":506,"name":"Capgemini","slug":"capgemini"}],"service":[{"id":243,"name":"Data &amp; AI","slug":"data-ai"}],"industry":[{"id":73,"name":"Life sciences","slug":"life-sciences"}],"blog-topic":[{"id":285,"name":"Innovation","slug":"innovation"},{"id":396,"name":"Technology","slug":"technology"}]},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"The future of pharma MES","url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini USA","logo":""},"keywords":[],"dateCreated":"2025-07-08T09:21:47Z","datePublished":"2025-07-08T09:21:47Z","dateModified":"2025-07-08T09:26:03Z"},"rendered":"<meta name=\"parsely-title\" content=\"The future of pharma MES\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2025-07-08T09:21:47Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"jetpack_featured_media_url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg","archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg","featured_image_alt":"","jetpack-related-posts":[{"id":748953,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/pharma-mes-whats-happening-now-and-whats-holding-us-back\/","url_meta":{"origin":748949,"position":0},"title":"Pharma MES: What\u2019s happening now and what\u2019s holding us back","author":"elishavalekar","date":"July 8, 2025","format":false,"excerpt":"Current State of Pharma MES","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":748945,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/mes-of-the-future-insights-from-mes-berlin\/","url_meta":{"origin":748949,"position":1},"title":"MES of the future: Insights from MES Berlin","author":"elishavalekar","date":"July 8, 2025","format":false,"excerpt":"MES of the future: Insights from MES Berlin","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog3-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog3-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog3-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog3-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":752606,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/clinical-and-commercial-data-integration-in-pharma\/","url_meta":{"origin":748949,"position":2},"title":"Clinical and commercial data integration in pharma","author":"elishavalekar","date":"September 23, 2025","format":false,"excerpt":"Clinical and commercial data integration in pharma","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/09\/Commercial-Data-Integration-blog-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/09\/Commercial-Data-Integration-blog-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/09\/Commercial-Data-Integration-blog-2880-x1880-px-dotcom-Banner.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/09\/Commercial-Data-Integration-blog-2880-x1880-px-dotcom-Banner.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":763061,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/jpm-healthcare-2026-signals-shaping-the-next-era-of-life-sciences-innovation\/","url_meta":{"origin":748949,"position":3},"title":"JPM Healthcare 2026: Signals shaping the next era of life sciences innovation","author":"elishavalekar","date":"February 11, 2026","format":false,"excerpt":"JPM Healthcare 2026 revealed a sector at a strategic inflection point. While headline announcements were fewer, the signals were louder: M&A is returning with purpose, AI has firmly crossed into production\u2011grade infrastructure, and pharma\u2019s role in care delivery is rapidly expanding. The conversations across San Francisco made one thing clear\u2014leaders\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":731820,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","url_meta":{"origin":748949,"position":4},"title":"Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical Applications","author":"elishavalekar","date":"November 19, 2024","format":false,"excerpt":"Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical ApplicationsCapgeminiNov 6, 2024 FacebookLinkedinThe BioTechX event in Basel in October was a major gathering for biotech and pharma professionals. This year, there was a different vibe compared to last year. This year's event marked a noticeable shift from the\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":748109,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/harnessing-predictive-analytics-to-transform-quality-in-civil-aeronautics\/","url_meta":{"origin":748949,"position":5},"title":"Harnessing predictive analytics to transform quality in civil aeronautics","author":"kosha.majmundar@capgemini.com","date":"June 30, 2025","format":false,"excerpt":"In the high-stakes world of civil aeronautics manufacturing, quality transcends metrics\u2014it\u2019s about safety, reliability, and reputation.","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/06\/AD_Aeroindia_dotcom_2880x1800px_20250109.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/06\/AD_Aeroindia_dotcom_2880x1800px_20250109.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/06\/AD_Aeroindia_dotcom_2880x1800px_20250109.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/06\/AD_Aeroindia_dotcom_2880x1800px_20250109.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini USA","distributor_original_site_url":"https:\/\/www.capgemini.com\/us-en","push-errors":false,"featured_image_url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts\/748949","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/users\/699"}],"replies":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/comments?post=748949"}],"version-history":[{"count":1,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts\/748949\/revisions"}],"predecessor-version":[{"id":748952,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts\/748949\/revisions\/748952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/media\/748950"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/media?parent=748949"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/categories?post=748949"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/tags?post=748949"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/brand?post=748949"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/service?post=748949"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/industry?post=748949"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/partners?post=748949"},{"taxonomy":"blog-topic","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/blog-topic?post=748949"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/content-group?post=748949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}